Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
04/01/1993 | WO1993006219A1 Secondary-metabolite biosynthesis genes from actinomycetes, method of isolating them, and their use |
04/01/1993 | WO1993006218A2 Chimeras of parainfluenza virus type 3 proteins f and hn as vaccines |
04/01/1993 | WO1993006217A1 EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab')2 ANTIBODIES |
04/01/1993 | WO1993006216A1 Fusion proteins targeted to lysosomes, for the treatment of aids |
04/01/1993 | WO1993006215A1 Receptor of the thyroid/steroid hormone receptor superfamily |
04/01/1993 | WO1993006214A1 Chimeric and/or growth-restricted flaviviruses |
04/01/1993 | WO1993006213A1 Production of chimeric antibodies - a combinatorial approach |
04/01/1993 | WO1993006210A1 New cell lines which support replication of baculoviruses |
04/01/1993 | WO1993006209A1 Genetically transformed pea plants and methods for their production |
04/01/1993 | WO1993006134A1 Factors for the cellular functional regulation and biological applications thereof |
04/01/1993 | WO1993006133A1 Immunoassay for identifying alcoholics and monitoring alcohol consumption |
04/01/1993 | WO1993006129A1 Polypeptide inhibitor of the replication of hsu and similar viruses |
04/01/1993 | WO1993006126A1 Immunoreactive hepatitis c virus polypeptide compositions |
04/01/1993 | WO1993006125A1 ISOLATION AND CHARACTERIZATION OF cDNA OF PLASMODIUM FALCIPARUM GLUCOSE-6-PHOSPHATE DEHYDROGENASE |
04/01/1993 | WO1993006123A1 Human cyclin e |
04/01/1993 | WO1993006122A1 Duplex-forming, polynucleotide conjugates |
04/01/1993 | WO1993006121A1 Method of synthesizing diverse collections of oligomers |
04/01/1993 | WO1993006116A1 Glial derived neurotrophic factor |
04/01/1993 | WO1993005817A1 Transgenic mhc class i and class ii antigen-deficient mammals |
04/01/1993 | WO1993005814A1 Competitive inhibition of t cell-b cell interactions |
04/01/1993 | WO1993005813A1 Method of producing antibodies to a restricted population of t lymphocytes, antibodies and method of use |
04/01/1993 | WO1993005810A1 VACCINE COMPRISING PART OF CONSTANT REGION OF IgE FOR TREATMENT OF IgE-MEDIATED ALLERGIC REACTIONS |
04/01/1993 | WO1993005786A1 Novel gabaa receptor with steroid binding sites |
04/01/1993 | WO1993005657A1 NOVEL BACILLUS THURINGIENSIS ISOLATE DENOTED B.t.PS158C2, ACTIVE AGAINST LEPIDOPTERAN PESTS, AND GENES ENCODING LEPIDOPTERAN-ACTIVE TOXINS |
04/01/1993 | WO1993005646A1 Reduction of nicotine levels in tobacco |
04/01/1993 | WO1993005645A1 Protection of plants against plant pathogens |
04/01/1993 | WO1993003187A3 Nucleic acid probes for the detection of shigella |
04/01/1993 | WO1993003148A3 Tau/neurofilament protein kinases pk40 and pk36 |
04/01/1993 | WO1993002217A3 Oligonucleotide probes for type determination and detection of human papillomaviruses |
04/01/1993 | WO1993001286A3 Localized oligonucleotide therapy |
04/01/1993 | WO1992020802A3 Novel bacillus thuringiensis isolates active against hymenopteran pests and genes encoding hymenopteran-active toxins |
04/01/1993 | DE4227882A1 Funktionalisierte traegermaterialien fuer gleichzeitige synthese und direktmarkierung von oligonukleotiden als primer fuer matrizenabhaengige enzymatische nukleinsaeuresynthesen Functionalized traegermaterialien for simultaneous synthesis and direct labeling of oligonucleotides as primers for enzymatic template-nukleinsaeuresynthesen |
04/01/1993 | CA2120036A1 Method of producing antibodies to a restricted population of t lymphocytes, antibodies produced therefrom and methods of use thereof |
04/01/1993 | CA2119927A1 Duplex-forming polynucleotide conjugates |
04/01/1993 | CA2119379A1 Secondary-metabolite biosynthesis genes from actinomycetes, method of isolating them and their use |
04/01/1993 | CA2119003A1 Factors for the cellular functional regulation and biological applications thereof |
04/01/1993 | CA2118938A1 Novel gabaa receptor with steroid binding sites |
04/01/1993 | CA2118806A1 Method of synthesizing diverse collections of oligomers |
04/01/1993 | CA2116976A1 Protection of plants against plant pathogens |
04/01/1993 | CA2116227A1 Annexin xi |
04/01/1993 | CA2115566A1 Polypeptide inhibitor of the replication of hsu and similar viruses |
04/01/1993 | CA2115452A1 Receptor of the thyroid/steroid hormone receptor superfamily |
03/31/1993 | EP0534878A1 Recombinant DNA molecules containing the coding part of a VBeta17 chain of the T cell antigen receptor and uses thereof |
03/31/1993 | EP0534858A1 Selective restriction fragment amplification : a general method for DNA fingerprinting |
03/31/1993 | EP0534742A1 Anti-human milk fat globule humanised antibodies |
03/31/1993 | EP0534705A2 Expression of low molecular weight recombinant polypeptides |
03/31/1993 | EP0534640A1 Process for detecting specific mRNA and DNA in cells |
03/31/1993 | EP0534619A2 Expression cloning method |
03/31/1993 | EP0534618A2 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
03/31/1993 | EP0534615A2 HLA-restricted hepatitis B virus CTL epitopes |
03/31/1993 | EP0534568A2 Human growth hormone analogues and their use |
03/31/1993 | EP0534526A1 Treponema hyodysenteriae vaccine |
03/31/1993 | EP0534383A2 Process for preparing human coagulation factor VIII protein complex |
03/31/1993 | EP0534345A2 Process for the specific production of ribonucleic acid |
03/31/1993 | EP0534102A1 Human cytomegalovirus specific peptides and use thereof |
03/31/1993 | EP0533952A1 Process for separating or extracting nucleic acid from specimen containing the same |
03/31/1993 | EP0533942A1 Process for expressing polypeptide |
03/31/1993 | EP0533913A1 Novel endopeptidase |
03/31/1993 | EP0533906A1 Detection of dna/rna by fluorescence polarization |
03/31/1993 | EP0533862A1 Recombinant human factor viii derivatives |
03/31/1993 | EP0533854A1 Pcr primers for detection of legionella species and methods for controlling visual intensity in hybridization assays |
03/31/1993 | EP0533849A1 SUCROSE PHOSPHATE SYNTHASE (SPS), ITS PROCESS FOR PREPARATION, ITS cDNA, AND UTILIZATION OF cDNA TO MODIFY THE EXPRESSION OF SPS IN THE PLANT CELLS |
03/31/1993 | EP0533846A1 The ciliary neurotrophic factor receptor |
03/31/1993 | EP0533841A1 Novel methods for producing antigen-specific, high-affinity human monoclonal antibodies |
03/31/1993 | EP0533838A1 Nucleic acid ligands |
03/31/1993 | EP0519053A4 Nucleic acid amplification with dna-dependent rna polymerase activity of rna replicases |
03/31/1993 | EP0517751A4 Shuttle plasmid for escherichia coli and mycobacteria |
03/31/1993 | EP0497894A4 Receptor infection assay |
03/31/1993 | EP0470976B1 Processes and compositions for the isolation of human relaxin |
03/31/1993 | EP0466854A4 T cell growth factor |
03/31/1993 | EP0281604B1 Single polypeptide chain binding molecules |
03/31/1993 | EP0253870B1 Method for producing factor viii:c-type proteins |
03/31/1993 | CN1070424A Ethanol production by recombinant hosts |
03/31/1993 | CN1070409A Prodrug activated by targeted catalytic proteins |
03/31/1993 | CN1070310A Regeneration and transformation of cotton |
03/31/1993 | CN1070309A Regeneration and transformation of cotton |
03/30/1993 | US5198542 Dna encoding a pitvitary adenylate cyclase activating protein and use thereof |
03/30/1993 | US5198535 Protective malaria sporozoite surface protein immunogen and gene |
03/30/1993 | US5198423 Inhibition of angiogenesis, wound healing |
03/30/1993 | US5198361 Plasmids for production of met-asp-gln bovine growth hormone, hosts containing the plasmids, products manufactured thereby and related methods |
03/30/1993 | US5198360 Microorganisms transformed with recombinant DNA vector |
03/30/1993 | US5198359 Recombinant protein receptor for il-2 |
03/30/1993 | US5198354 Genetic engineering |
03/30/1993 | US5198348 Yeast cell transformation vectors, Saccharomyces |
03/30/1993 | US5198347 Dna encoding plasmodium vivax and plasmodium knowlesi duffy receptor |
03/30/1993 | US5198346 Generation and selection of novel DNA-binding proteins and polypeptides |
03/30/1993 | US5198345 Aspergillus, DNA construct for transforming host |
03/30/1993 | US5198344 DNA sequence that encodes the multidrug resistance gene |
03/30/1993 | US5198343 Method for expressing a heterologous protein in a dapD- mutant of E. coli and the strain obtained |
03/30/1993 | US5198342 DNA encoding IgA Fc receptors |
03/30/1993 | US5198011 Methods for inhibiting rust infections of plants |
03/30/1993 | US5197973 Polypeptide |
03/30/1993 | CA1315226C Process for preparation of improved mutant strain of bordetella bronchiseptica useful for live attenuated vaccine for protection of b. bronchiseptica infection and live attenuatedar vaccine produced therefrom |
03/30/1993 | CA1315225C Polypeptide useful for the allevation, treatment and diagnosis of auto-immune diseases, especially arthritic conditions, etc. |
03/30/1993 | CA1315224C Biological containment |
03/30/1993 | CA1315223C Method for mutagenesis by oligonucleotide-directed repair of a strand break |
03/30/1993 | CA1315219C Monoclonal antibodies against human carcinoembryonic antigen, processes for their production and their use |
03/28/1993 | WO1993006244A1 An assay for a new gaucher disease mutation |
03/28/1993 | WO1993006225A1 Method of production of poly-beta-hydroxyalkanoate copolymers |
03/28/1993 | CA2120128A1 Method of production of poly-beta-hydroxyalkanoate copolymers |